http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
성인의 T - lymphoblastic Lymphoma 의 임상상과 Modified LSA2 - L2 화학요법의 치료성적
김인순(In Soon Kim),한동수(Dong Soo Han),최영춘(Young Chun Choi),이영열(Young Yiul Lee),정태준(Tae Joon Chung),최일영(Il Young Choi),고영혜(Young Hyeh Ko),이중달(Jung Dal Lee) 대한내과학회 1989 대한내과학회지 Vol.37 No.1
N/A Adult T-lymphoblastic lymphoma was first described by Barcos and Lukes in 1974. It is famous for early systemic metastasis and should be treated systematically as soon as possible. We diagnosed 8 adult T-lymphoblasic lymphomas by means of clinical manifestation, tissue biopsy and their immunophenotyping from May 1986 to September 1988. Seven cases were treated with an aggressive regimen, the modified LSA2-L2 protocol. The results were as follows: 1) The median age in the group was 24 years (range 17 -35). 2) At diagnosis, all patients had mediastinal involvement, and 5 patients had bone marrow involvement. Three patients demonstrated malignant cells in the peripheral blood. 3) Six patients were positive for Tdt stain and 4 patients were CD7 (+). 4) Complete clinical response was attained in all patients with induction therapy including cytoxan, vincristine, and adriamycin. 5) Two complete responders who did not take the prescribed chemotherapeutic medication and CNS prophylaxis have had relapses in the CNS and testis. In summary, adult T-lymphoblastie lymphoma is a very aggressive and systemic disease. Systemic chemotherapy with CNS prophylaxis, such as the modified LSA2-L2 protocol, should be recommended.
우리 주변의 non - A , non - B 형 급성 바이러스간염
정규원,김부성,정환국,백남종,정태준 대한소화기학회 1979 대한소화기학회지 Vol.11 No.2
In order to evaluate the incidence and mode of infection of acute viral hepatitis, type A, B and so-called non-A, non-R, the study on immune markers of hepatitis A virus (HAV) and hepatitis B virus (HBV) using radioimmunoassay (RIA) technique was performd on normal populations of 80 healthy Korean and 6 foreigners residing in Korea and on biopsy- proven 82 patients with acute viral hepatitis, including 77 Koreans & 5 foreigners admitted to St. Mary's Hospital, Catholic Medical College, and Capital Armed Forccs General Hospital, Seoul, Korea from January, 1971 to September, 1979. The results were as follows: 1. In normal population the incidence of HRsAg and anti-HBc positive HBV carrier was 100% in 21 to 30 year-old age group, 80%, in over 50 year-old group and 50 to 70% in other age groups. 2. The incidence of anti-HAV as an immune marker of HAV infection was almost 40% in healthy Korean be1ow 1 year-old age group and 50%, below 10 year-old but all the cases over 10 year-old examined had the evidence of infection and immunity to HAV. It is, therefore, suggested that the apparent infection of HAV is hardly seen in normal population after the age of 11 in Korea. Of the 77 cases of acute viral hpeatitis prevalent among Korean, anti-HA alone was detected in only 5.1%. The incidence of anti-HA positivity in healthy foreigners residing in Korea was similar to that of about 40g in normal adults in the United States. This study suggests that the majority of acute viral hepatitis prevalent in Korea is type B, and that the incidence of non-A non-B hepatitis is presummed at least over 5% of acute viral hepatitis in Korea.
신창록,심종걸,전용철,권기운,이영열,김인순,정태준,최일영 대한내과학회 1990 대한내과학회지 Vol.38 No.5
An analysis of 50 patients with metastatic carcinoma from unknown primary site, seen at Hanyang University Hospital from january 1985 to December 1987, was performed. 50 patients constituted 2.4% of the total carcinoma patients registered at Hanyang University Hospital. The mean age of the patients was 55.1 years. Histopathologic diagnosis revealed adenocarcinoma in 68% and squamous cell carcinoma in 20% of the cases. The common sites of metastases were the lymphnodes, pleura, peritoneum and bones. The overall median survival time was 4.5 months. The primary sites were identified in only four patients(8%) during the follow-up periods. There was no difference in survival time between treated and untreated adenocarcinoma patients, but in squamous cell carcinoma patients group survival for treated versus untreated was 12.8 months versus 1.7 months.